Teva Respiratory News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Teva respiratory. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Teva Respiratory Today - Breaking & Trending Today

Amphastar Receives FDA Approval for Albuterol Sulfate Inhalation Aerosol

RANCHO CUCAMONGA, CA / ACCESSWIRE / May 22, 2024 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) today announced that the U.S. Food and Drug Administration ("FDA") has granted approval for the Company's Abbreviated New Drug Application ("ANDA") for Albuterol Sulfate Inhalation Aerosol, previously. ....

United States , Jack Zhang , Amphastar Pharmaceuticals Inc , Company Abbreviated New Drug Application , Amphastar Nanjing Pharmaceuticals , Company Information , Exchange Commission , Drug Administration , Co Ltd , Most Of The Company , Teva Respiratory , Amphastar Pharmaceuticals , Abbreviated New Drug Application , Albuterol Sulfate Inhalation Aerosol , Inhalation Aerosol , Drug Master Files , Annual Report , Quarterly Report ,

Amphastar Pharmaceuticals, Inc. Receives FDA Approval for Albuterol Sulfate Inhalation Aerosol

Amphastar Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration has granted approval for the company s Abbreviated New Drug Application for Albuterol Sulfate Inhalation Aerosol,. ....

Teva Respiratory , Drug Administration , Amphastar Pharmaceuticals Inc , Amphastar Pharmaceuticals , Abbreviated New Drug Application , Albuterol Sulfate Inhalation Aerosol ,